➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Mallinckrodt
Johnson and Johnson
Express Scripts
Dow

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

SODIUM FLUORIDE F 18 Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Sodium Fluoride F 18, and when can generic versions of Sodium Fluoride F 18 launch?

Sodium Fluoride F 18 is a drug marketed by Nih Nci Dctd and is included in one NDA.

The generic ingredient in SODIUM FLUORIDE F 18 is sodium fluoride f-18. There are one thousand four hundred and seventy-two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the sodium fluoride f-18 profile page.

US ANDA Litigation and Generic Entry Outlook for Sodium Fluoride F 18

A generic version of SODIUM FLUORIDE F 18 was approved as sodium fluoride f-18 by SOFIE on December 26th, 2012.

  Start Trial

Summary for SODIUM FLUORIDE F 18
Drug patent expirations by year for SODIUM FLUORIDE F 18
Recent Clinical Trials for SODIUM FLUORIDE F 18

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
ECOG-ACRIN Cancer Research GroupPhase 3
Cairo UniversityPhase 2/Phase 3
University of New EnglandEarly Phase 1

See all SODIUM FLUORIDE F 18 clinical trials

US Patents and Regulatory Information for SODIUM FLUORIDE F 18

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nih Nci Dctd SODIUM FLUORIDE F 18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 022494-001 Jan 26, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Harvard Business School
Medtronic
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.